Tabula Rasa HealthCare (TRHC) Misses Q2 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Tabula Rasa HealthCare Reports Second Quarter 2022 Results
August 4, 2022 4:30 PM EDTRevenue from continuing operations of $72.6 million increased 13% vs. a year ago, driven by CareVention HealthCare revenue growth of 17%.GAAP net loss from continuing operations of $12.7 million vs. $14.1 million a year ago and $20.4 million in Q1 2022.Adjusted EBITDA from continuing operations of $2.1 million vs. $3.3 million a year ago and $1.1 million in Q1 2022.Cash of $26.5 million as of June 30, 2022, up $12.1 million on a sequential basis vs. Q1 2022.
MOORESTOWN, N.J., Aug. 4, 2022 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (Nasdaq: TRHC), a leading healthcare technology company advancing the safe... More
